Abstract
Using high-resolution array-CGH, we identified unique duplications of a region on 6q27 in four multiplex families with at least three cases of chordoma, a cancer of presumed notochordal origin. The duplicated region contains only the T (brachyury) gene, which is important in notochord development and is expressed in most sporadic chordomas. Our findings highlight the value of screening for complex genomic rearrangements in searches for cancer-susceptibility genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
References
McCarroll, S.A. & Altshuler, D.M. Nat. Genet. 39, S37–S42 (2007).
Inoue, K. & Lupski, J.R. Annu. Rev. Genomics Hum. Genet. 3, 199–242 (2002).
Lupski, J.R. Nat. Genet. 39, S43–S47 (2007).
Padiath, Q.S. et al. Nat. Genet. 38, 1114–1123 (2006).
Le Maréchal, M.C. et al. Nat. Genet. 38, 1372–1374 (2006).
Lee, J.A. & Lupski, J.R. Neuron 52, 103–121 (2006).
Malawer, MM, Link, MP & Donaldson, SS in Sarcomas of Bone (eds. Devita, V.T., Hellman, S. & Rosenberg, S.A.) 844–1846 (Lippincott-Raven, Philadelphia, 1997).
Kelley, M.J. et al. Am. J. Hum. Genet. 69, 454–460 (2001).
Yang, X.R. et al. Int. J. Cancer 116, 487–491 (2005).
Kispert, A., Koschorz, B. & Herrmann, B.G. EMBO J. 14, 4763–4772 (1995).
Kispert, A. & Herrmann, B.G. Dev. Biol. 161, 179–193 (1994).
Vujovic, S. et al. J. Pathol. 209, 157–165 (2006).
Chanda, B. et al. Hum. Mol. Genet. 17, 3446–3458 (2008).
Acknowledgements
We thank D. Zametkin for her outstanding skills as a research nurse; G.M. Glenn and M.L. McMaster for their careful clinical evaluations of affected individuals and family members; N.J. Patronas for reviewing the MRIs; A. Bergen and S. Chanock for SNP genotyping; K. Haque and D. Maeder for technical assistance; and, especially, the affected individuals and their families for their participation. This work was supported by the intramural research program of the US National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Institutes of Health; by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development program; and by a grant from the Chordoma Foundation (M.J.K.).
Author information
Authors and Affiliations
Contributions
X.R.Y. wrote the first draft of the paper; X.R.Y. and D.N. analyzed the data; D.N., S.L., M.J.K. and D.A.A. performed the laboratory studies, including genotyping, sequencing and breakpoint evaluation; D.N. designed and conducted qPCR analyses; D.M.P. initiated the clinical study and evaluated the chordoma-affected families with D.N.; D.M.P., E.S. and N.J.L. collected the families; X.R.Y., D.N., M.J.K., D.M.P. and A.M.G. planned the work and interpreted the results. All authors contributed to the final version of the paper.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Methods, Supplementary Tables 1 and 2 and Supplementary Figures 1–3 (PDF 2096 kb)
Rights and permissions
About this article
Cite this article
Yang, X., Ng, D., Alcorta, D. et al. T (brachyury) gene duplication confers major susceptibility to familial chordoma. Nat Genet 41, 1176–1178 (2009). https://doi.org/10.1038/ng.454
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.454
This article is cited by
-
Conserved enhancers control notochord expression of vertebrate Brachyury
Nature Communications (2023)
-
Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery
Journal of Neuro-Oncology (2023)
-
Chordoma: demographics and survival analysis with a focus on racial disparities and the role of surgery, a U.S. population-based study
Clinical and Translational Oncology (2023)
-
Activation of Wnt Pathway Suppresses Growth of MUG-Chor1 Chordoma Cell Line
Cell Biochemistry and Biophysics (2023)
-
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Current Medicine (2023)